Oregovomab

Oregovomab
Monoclonal antibody
Type	Whole antibody
Source	Template:Infobox drug/mab source
Target	CA125
Identifiers
CAS Number	213327-37-8
ATC code	none
Chemical data
Molar mass	ca. 150 kDa

Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Oregovomab (marketed under the trade name OvaRex) is a mouse monoclonal antibody it binds to the antigen CA125, a carbohydrate antigen. It is designed for the treatment of ovarian cancer.^[1]

This drug was developed by AltaRex Corp.

References

This monoclonal antibody-related article is a stub. You can help ssf by expanding it.

v t e Mouse monoclonal antibodies ("-o-")
"-govo-" (ovarian tumor)	Abagovomab, Igovomab, Oregovomab
"-limo-" (immune system)	Afelimomab, Elsilimomab, Faralimomab, Gavilimomab, Inolimomab, Maslimomab, Nerelimomab, Odulimomab, Telimomab aritox, Vepalimomab, Zolimomab aritox
"-tumo-" (miscellaneous tumor)	Altumomab pentetate, Anatumomab mafenatox, Arcitumomab, Bectumomab, Blinatumomab, CC49, Detumomab, Ibritumomab tiuxetan, Minretumomab, Mitumomab, Naptumomab estafenatox, Nofetumomab merpentan, Pemtumomab, Pintumomab, Satumomab pendetide, Taplitumomab paptox, Tenatumomab, Tositumomab, 3F8
"-leso-" (infectious lesions)	Besilesomab, Fanolesomab^§, Lemalesomab, Sulesomab
"-ciro-" (cardiovascular)	Biciromab^§, Imciromab^§
"-pro-" (prostate tumor)	Capromab pendetide
"-baco-" (bacterial)	Edobacomab
"-colo-" (colonic tumor)	Edrecolomab, Nacolomab tafenatox
^§Withdrawn